BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 16407849)

  • 1. The carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells.
    Chen J; Kremer CS; Bender TP
    Oncogene; 2006 May; 25(19):2758-72. PubMed ID: 16407849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M; Boss GR; Pascual FE; Pilz RB
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel system to identify Myb target promoters in friend murine erythroleukemia cells.
    Chen J; Bender TP
    Blood Cells Mol Dis; 2001; 27(2):429-36. PubMed ID: 11500057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state.
    Chen J; Kremer CS; Bender TP
    Oncogene; 2002 Mar; 21(12):1859-69. PubMed ID: 11896618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cAMP-induced NF-kappaB (p50/relB) binding to a c-myb intronic enhancer correlates with c-myb up-regulation and inhibition of erythroleukemia cell differentiation.
    Suhasini M; Reddy CD; Reddy EP; DiDonato JA; Pilz RB
    Oncogene; 1997 Oct; 15(15):1859-70. PubMed ID: 9362453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GATA-1 and c-myb crosstalk during red blood cell differentiation through GATA-1 binding sites in the c-myb promoter.
    Bartůnek P; Králová J; Blendinger G; Dvorák M; Zenke M
    Oncogene; 2003 Apr; 22(13):1927-35. PubMed ID: 12673198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of protooncogenes c-myb and c-myc during the hexamethylene bisacetamide (HMBA)-induced commitment to terminal differentiation of murine erythroleukemia cells].
    Chen ZX
    Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):261-4. PubMed ID: 1806345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application.
    Marks PA; Rifkind RA
    Int J Cell Cloning; 1988 Jul; 6(4):230-40. PubMed ID: 3047266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the transcriptional factor GATA-1 in regulation of expression of coproporphyrinogen oxidase in mouse erythroleukemia cells.
    Tanabe A; Furukawa T; Ogawa Y; Yamamoto M; Hayashi N; Tokunaga R; Taketani S
    Biochem Biophys Res Commun; 1997 Apr; 233(3):729-36. PubMed ID: 9168923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
    Lennartsson A; Garwicz D; Lindmark A; Gullberg U
    Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELC.
    Marks PA; Michaeli J; Jackson J; Richon VM; Rifkind RA
    Prog Clin Biol Res; 1989; 316B():171-81. PubMed ID: 2616574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional elongation of c-myb is regulated by NF-kappaB (p50/RelB).
    Suhasini M; Pilz RB
    Oncogene; 1999 Dec; 18(51):7360-9. PubMed ID: 10602492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
    Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
    Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-myb effects on kinetic events during MEL cell differentiation.
    Danish R; el-Awar O; Weber BL; Langmore J; Turka LA; Ryan JJ; Clarke MF
    Oncogene; 1992 May; 7(5):901-7. PubMed ID: 1533276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatin immunoselection defines a TAL-1 target gene.
    Cohen-Kaminsky S; Maouche-Chrétien L; Vitelli L; Vinit MA; Blanchard I; Yamamoto M; Peschle C; Roméo PH
    EMBO J; 1998 Sep; 17(17):5151-60. PubMed ID: 9724651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation.
    Marks PA; Ramsay R; Sheffery M; Rifkind RA
    Prog Clin Biol Res; 1987; 251():253-68. PubMed ID: 3481077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditional inhibition of erythroid differentiation by c-Myb/oestrogen receptor fusion proteins.
    Lyon JJ; Watson RJ
    Differentiation; 1995 Oct; 59(3):171-8. PubMed ID: 7589901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myb proteins regulate the expression of diverse target genes.
    Lang G; White JR; Argent-Katwala MJ; Allinson CG; Weston K
    Oncogene; 2005 Feb; 24(8):1375-84. PubMed ID: 15608679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA binding-independent transcriptional activation of the vascular endothelial growth factor gene (VEGF) by the Myb oncoprotein.
    Lutwyche JK; Keough RA; Hunter J; Coles LS; Gonda TJ
    Biochem Biophys Res Commun; 2006 Jun; 344(4):1300-7. PubMed ID: 16650815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation.
    Rao G; Rekhtman N; Cheng G; Krasikov T; Skoultchi AI
    Oncogene; 1997 Jan; 14(1):123-31. PubMed ID: 9010239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.